Quantitative analysis of cerebral vasculopathy in patients with Fabry disease

Neurology
K E CrutchfieldRaphael Schiffmann

Abstract

This study's purpose was to obtain a quantitative natural history of the cerebrovascular involvement in Fabry disease. Fabry disease is an X-linked recessive disorder due to alpha-galactosidase A deficiency. Progressive accumulation of ceramidetrihexoside within the intima and media of cerebral blood vessels causes ischemic lesions in the majority of affected patients. Determination of the natural history of the cerebral vasculopathy in Fabry disease is important to assess the effects of therapeutic intervention in this disorder. A longitudinal MRI study of 50 patients who had a total of 129 MRI scans was performed. The burden of cerebrovascular disease was determined using direct linear measurement. On T2-weighted MRI scans, 32% of the patients had no lesions (mean age, 33 years), 16% had gray matter lesions only (mean age, 36 years), 26% had lesions in white matter only (mean age, 43 years), and 26% had lesions in white and gray matter (mean age, 47 years). Disease burden increased with age, but no patient younger than 26 had lesions on MRI. All patients older than 54 had cerebrovascular involvement. The distribution of MRI-detectable lesions was typical of a small-vessel disease. Only 37.5% of patients with cerebral lesions ...Continue Reading

Citations

Mar 17, 2006·Journal of Neurology·Silvia MarinoNicola De Stefano
Mar 3, 2006·Journal of Neurology·Andreas FellgiebelMatthias J Müller
Dec 25, 2009·Journal of Neurology·José Fidel Baizabal-Carvallo, Yves Samson
Nov 1, 2011·Journal of Neurology·Miguel Viana-Baptista
Sep 21, 2011·Journal of Inherited Metabolic Disease·Andreas FellgiebelMatthias J Müller
Mar 20, 2010·Journal of Human Genetics·Katsuya NakamuraShu-ichi Ikeda
Feb 7, 2007·Nature Clinical Practice. Neurology·Anette T Møller, Troels S Jensen
May 25, 2006·Acta Paediatrica. Supplement·Lionel GinsbergAlessandro P Burlina
Feb 17, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Markus RiesDonna Krasnewich
Mar 15, 2006·The Neurologist·Juan M Politei, Aristides A Capizzano
Dec 20, 2007·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Henriette MersebachUlla Feldt-Rasmussen
Apr 16, 2008·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Riki Okeda, Masahiro Nisihara
Jul 21, 2001·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·D F MooreR Schiffmann
Feb 1, 2007·International Journal of Clinical Practice·O LidoveT Papo
Apr 24, 2007·Journal of Neurology, Neurosurgery, and Psychiatry·J AlbrechtA Fellgiebel
Nov 26, 2010·Orphanet Journal of Rare Diseases·Dominique P Germain
Jun 4, 2013·European Journal of Internal Medicine·Daniel FranzenFrederic Barbey
Nov 7, 2008·Expert Review of Neurotherapeutics·Kavita Kalidas, Réza Behrouz
May 31, 2002·Expert Opinion on Investigational Drugs·Michael Beck
May 29, 2015·Journal of Magnetic Resonance Imaging : JMRI·Hunter R UnderhillC Ronald Scott
Apr 6, 2011·Journal of the Neurological Sciences·Ricardo C ReisinGustavo Sevlever
Sep 4, 2010·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Hiroo IchikawaMitsuru Kawamura
Oct 1, 2010·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Hiroo IchikawaMitsuru Kawamura
Nov 11, 2009·Molecular Genetics and Metabolism·S M RombachC E M Hollak
Feb 3, 2009·Journal of the Neurological Sciences·M YamaderaS Sakoda
Jul 27, 2002·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Fiona J CarrAnna F Dominiczak
Apr 9, 2008·Clinical Therapeutics·Anette Torvin Møller, Troels Staehelin Jensen
Mar 17, 2007·Journal of the Neurological Sciences·David F MooreRaphael Schiffmann
Jan 24, 2007·Lancet Neurology·Martin Dichgans
Jan 24, 2007·Lancet Neurology·Lionel GinsbergJan-Willem Taanman
Jan 20, 2007·Clinical Neurology and Neurosurgery·Sabahattin SaipGokhan Erkol
Feb 6, 2004·Journal of the European Academy of Dermatology and Venereology : JEADV·M R BongiornoM Aricò
Mar 19, 2016·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Yu KonoYasuyuki Iguchi
Sep 9, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Susanne BuechnerWalter Borsini
Mar 30, 2007·Acta Paediatrica. Supplement·Andreas FellgiebelMatthias J Müller
Sep 29, 2011·CNS Neuroscience & Therapeutics·Arezoo AssarehPerminder S Sachdev
Mar 21, 2012·Acta Neurologica Scandinavica·A BersanoP Baron
Aug 14, 2012·Clinical Genetics·L BorgwardtA Meldgaard Lund
Jun 4, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·K NakamuraS-I Ikeda
Jun 4, 2015·Journal of Neurology·Rhea Y Y Tan, Hugh S Markus
Jul 20, 2005·The Journal of Pediatrics·Mario A Cabrera-SalazarJohn A Barranger
Jul 9, 2010·The American Journal of Medicine·Frank WeidemannChristoph Wanner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.